Mouth cancer, also known as oral cancer, is a type of head and neck cancer that originates in the oral cavity and develops in the lips, tongue, gums, cheeks, salivary glands, and the roof of the mouth. It is essential to understand the causes, symptoms, and warning signs to enable early detection and prevention. Causes […]
Osimertinib, a revolutionary drug in treating EGFR-mutant non-small cell lung cancer (NSCLC), is making waves in oncology. Osimertinib, also known as Tagrisso. Developed initially as a second-line treatment for patients with resistant forms of lung cancer, Osimertinib has gained importance as a first-line therapy in recent years. With its ability to target specific mutations and prolong […]
Breast cancer is a complex disease, and its progression is often described in stages. These stages help doctors understand how far it has spread and determine the best course of treatment. Knowing the stage of your breast cancer is essential because it helps decide the best treatment. What are the Stages of Breast Cancer? There […]
According to the American Cancer Society (ACS), Breast cancer is one of the most common cancers affecting women worldwide, and females in the U.S. have a 13% chance of developing breast cancer. However, breast cancer can affect people of any gender or sex. Breast Cancer occurs when cells in the breast start to grow uncontrollably and […]
Breast cancer is a significant health concern, being the second most diagnosed cancer among women worldwide. It can also occur in men. It affects approximately 1 in 8 women in the U.S., underscoring the importance of awareness and early detection. The disease develops when breast tissue cells grow uncontrollably. This abnormal growth leads to the […]
On October 10, 2024, the Food and Drug Administration (FDA) approved Inavolisib, in combination with Palbociclib and Fulvestrant, for adults with advanced breast cancer that meets specific criteria. This approval is essential for patients who have: Endocrine-resistant breast cancer PIK3CA-mutated tumors Hormone receptor (HR)-positive status HER2-negative status Locally advanced or metastatic disease, as identified by an FDA-approved […]
